Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
FirstHealth Opens Cardiac and Vascular Institute
FirstHealth celebrated the opening of the Reid Heart Center Cardiac and Vascular Institute in December of 2010. The 186,000-sf facility is located on the Moore Regional Hospital campus in Pinehurst, N.C. The center features 30 critical care beds, 27 cardiology/telemetry beds, six surgical suites, five cardiac catheterization labs, and two electrophysiology suites. The facility was designed by HKS of Richmond, Va., and built by Brasfield and Gorrie of Raleigh, N.C.
Providence Regional Medical Center Everett Nears Completion
The $500 million Providence Regional Medical Center Everett will open in 2011. Built as twin towers, the 12-story, 700,000-sf hospital will support patient and family centered care with 368 beds, an expanded emergency department, and a digital imaging center. General contractor M.A. Mortenson Co. broke ground on the facility in October of 2008.
BD Attains LEED Silver for Diagnostics Facility
Medical technology company BD was awarded LEED Silver sustainable design certification in December of 2010 for the $14 million BD Diagnostics – Women’s Health and Cancer facility. Located in Mebane, N.C., the 101,000-sf building features advanced lighting and HVAC systems and low emission interior finishes. The facility opened in May of 2010 and is expected to use 25 percent less energy than a comparable conventional structure.
Florida Hospital Partners with Sanford Burnham to Build Translational Research Institute
Florida Hospital is partnering with Sanford Burnham Medical Research Institute to build the Translational Research Institute for Metabolism and Diabetes. The 54,000-sf facility is under construction in Florida Hospital’s Health Village in Orlando. Occupancy is expected in late 2011.
UCB Expands Microbial Manufacturing Facilities
UCB is investing EU250 million to expand its facilities in Bulle, Switzerland. A microbial manufacturing unit will be built to produce a treatment for rheumatoid arthritis and Crohn's disease. The expansion is slated for completion in 2015. UCB is also constructing a bioprocessing pilot plant in Belgium.